David Paula, Shoenfeld Yehuda
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Laboratory of the Mosaics of Autoimmunity, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Isr Med Assoc J. 2020 Jul;22(7):401-403.
There is a high prevalence of olfaction changes, especially in the early presentation, in COVID-19 patients. The mechanisms through which the virus leads to anosmia/hyposmia is still not fully understood. However, olfaction changes could be used as an indication for testing or quarantine. Screening for infections and other diseases by recognizing volatile organic compounds (VOCs) has been previously conducted. Hence, if the coronavirus infection also results in VOCs excretion, physicians could "smell" the virus by using electronic noses. We conducted a literature review on olfaction changes and the COVID-19. Our results suggest that these changes could be used an indication for early testing, even as an isolated symptom. We propose that the electronic nose be used as a future screening tool, especially in agglomeration spaces such as airports, for screening for the COVID-19 infection.
嗅觉改变在新冠肺炎患者中非常普遍,尤其是在疾病早期表现时。病毒导致嗅觉丧失/嗅觉减退的机制仍未完全明确。然而,嗅觉改变可作为检测或隔离的指征。此前已有通过识别挥发性有机化合物(VOCs)来筛查感染及其他疾病的做法。因此,如果新冠病毒感染也会导致VOCs排出,医生就可以使用电子鼻“嗅出”病毒。我们对嗅觉改变与新冠肺炎进行了文献综述。我们的结果表明,这些改变可作为早期检测的指征,甚至作为单一症状时也可如此。我们建议将电子鼻用作未来的筛查工具,尤其是在机场等聚集场所,用于筛查新冠病毒感染。